[1]
Wang, Y. et al. 2024. Suppression of Epidermal Growth Factor Receptor by Erlotinib Attenuates Carvacrol-induced Skin Inflammation. Acta Dermato-Venereologica. 104, (Dec. 2024), adv40975. DOI:https://doi.org/10.2340/actadv.v104.40975.